Complementary Acquisition Expands Kewaunee’s Product Offerings and Market Reach Carl Marks Securities, an affiliate of middle market investment bank Carl Marks Advisors, today announced that it has ...

Exactech, a global medical technology leader, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Truliant® Porous Tibial Tray, a 3D tibial knee ...

Immorta Bio, a scientific longevity company focused on “Treating Diseases of Aging and Treating Aging as Disease™,” announced today successful treatment of aggressive breast cancer in animal models ...

Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, announced today the appointment of seasoned medical device executive Jay Hallinan as ...

The MedTech industry continues to thrive and innovate. According to Markets and Market’s “The Global MedTech Industry Outlook 2024” report, the MedTech market is expected to grow 4% in 2024 to $668.2B ...

Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring DELFI Diagnostics, Inc., developer of accessible blood-based ...

Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the second closing of its Series A ...

GT Metabolic Solutions Inc., the global leader in magnetic compression anastomosis surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared GT Metabolic’s MagDI™ System for ...

SPIRARE II U.S. Pivotal Trial Commences Studying System Designed to Bring the Precision and Control of Direct Surgical Access to Catheter-Based Interventions Jupiter Endovascular, Inc., a medical ...

Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced positive six-month data from the PINNACLE I study evaluating the safety and performance of its ...

Elucid has announced that Noridian will extend coverage for AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, beginning December 8, 2024.

Masonicare at Ashlar Village senior living community became the third Purple Flag™ community nationwide to celebrate its reaccreditation in dementia care. With this flag-raising, Masonicare becomes ...